In the forests and cities of northeastern Democratic Republic of Congo, a virus older than its recognition is rewriting records. The Bundibugyo strain of Ebola — for which no approved vaccine or treatment exists — has now claimed nearly 3,000 confirmed lives among more than 6,000 known cases, surpassing every previous outbreak in the country's history. What began undetected as early as February has become a test not only of a health system's capacity, but of humanity's ability to respond to a pathogen that moved faster than the systems designed to catch it.
DR Congo Ebola outbreak surpasses 6,000 cases, becomes nation's worst epidemic
2911 deaths confirmed among 6041 infected cases, with experts estimating significantly higher unreported mortality.
The virus spread undetected for three months before anyone knew it was there.
Mark
So this is the worst Ebola outbreak the DRC has ever seen. What makes this one different from the 2018 outbreak that lasted two years?
Mimi
The Bundibugyo strain. The previous outbreak was Zaire strain, and we have vaccines and treatments for that. This one has neither—no approved vaccine, no approved treatment. That's the core problem.
Luke
But wait—they're running trials on Ervebo now, which is approved for Zaire. Do we know if it will work on Bundibugyo?
Mimi
That's exactly what the trial is supposed to tell us. They just started it. We don't have an answer yet.
Mark
The numbers are staggering—6,000 cases, nearly 3,000 dead. But you mentioned experts think the real number is much higher.
Mimi
Yes. The outbreak was announced in May, but infections likely started in February. That's three months of undetected spread. And experts say there's a high number of unreported cases now.
Luke
How high? Do we have any estimate?
Mimi
The source doesn't give a specific number. It just says experts believe there's a high number unreported. That's the limit of what we know.
Mark
So the death toll could be significantly worse than 2,911.
Mimi
Almost certainly. But we can only confirm what's been reported.
Luke
And the antiviral trials—when did those start?
Mimi
Early July. Two different treatments in clinical trials. So we're maybe two months in.
Mark
That's fast for a trial.
Luke
It is, but we don't know if they're showing promise or hitting problems. The source just says they're underway.
Il Polso
- With 6,041 confirmed cases and 2,911 deaths, DR Congo's Bundibugyo Ebola outbreak has become the largest in the nation's history — and experts warn the true toll is almost certainly higher.
- The virus spread silently for months before detection, giving it a head start that has left response teams scrambling across six provinces to contain what three provinces have already been devastated by.
- The Bundibugyo strain's resistance to existing medical countermeasures — no approved vaccine, no approved treatment — has stripped responders of the tools that helped tame previous outbreaks.
- Only 619 people are currently in treatment or isolation, a figure that exposes how severely the outbreak has outpaced the health system's ability to identify, isolate, and care for the sick.
- Clinical trials for two antiviral treatments and a vaccine trial using Ervebo — approved for a different Ebola strain — have now begun, offering the first real chance to test interventions as the crisis unfolds.
In the forests and cities of northeastern Democratic Republic of Congo, a virus older than its recognition is rewriting records. The Bundibugyo strain of Ebola — for which no approved vaccine or treatment exists — has now claimed nearly 3,000 confirmed lives among more than 6,000 known cases, surpassing every previous outbreak in the country's history. What began undetected as early as February has become a test not only of a health system's capacity, but of humanity's ability to respond to a pathogen that moved faster than the systems designed to catch it.
The Democratic Republic of Congo is facing the worst Ebola outbreak in its recorded history. By late August, authorities had confirmed 6,041 infections and 2,911 deaths — figures that have already surpassed the devastating 2018–2020 epidemic. The cause is the Bundibugyo strain, a variant for which no approved vaccine or treatment exists, making containment far harder than in previous crises.
The outbreak's origins compound the challenge. Though the World Health Organisation announced the emergency in mid-May, experts believe the virus was circulating undetected as early as February — a months-long lag that allowed it to gain significant ground before any formal response began. Health authorities have openly acknowledged that confirmed case numbers likely undercount the true scale of infection across affected regions.
Three northeastern provinces — Ituri, North Kivu, and Haut-Uele — have borne the heaviest losses, with response teams now operating across six provinces in total. Yet only 619 people are currently in treatment or isolation, a stark measure of how far the outbreak has outrun the health system's capacity. Investigators from the Africa CDC have examined whether the Bundibugyo strain may have mutated to become more transmissible, though testing has not confirmed that suspicion.
There are cautious signs of progress. Clinical trials for two antiviral treatments began in July, and a vaccine trial using Ervebo — already approved against the Zaire strain — has recently commenced. Whether Ervebo will prove effective against Bundibugyo is unknown, but these trials represent the first real opportunity to test medical tools in real time. How quickly they can generate usable results may determine whether the trajectory of an epidemic that has already claimed nearly 3,000 lives can be bent.
The Democratic Republic of Congo is now contending with the largest Ebola outbreak in its recorded history. As of late August, authorities confirmed 6,041 cases of infection and 2,911 deaths—numbers that have already eclipsed the previous worst epidemic, which unfolded across 2018 and 2020. The culprit is the Bundibugyo strain of Ebola, a variant for which no vaccine has yet been approved and no specific treatment exists, making containment extraordinarily difficult.
The speed and scale of this outbreak have alarmed epidemiologists worldwide. The World Health Organisation first announced the crisis in mid-May, but by that point the virus had already gained substantial ground. Experts now believe the first infections likely occurred as early as February, spreading undetected for months before the outbreak was formally recognized. This lag between emergence and detection suggests the true scope of the epidemic may be far larger than confirmed figures indicate—a concern health authorities have openly acknowledged, noting a high likelihood of unreported cases across affected regions.
Three provinces have borne the brunt of the outbreak: Ituri, North Kivu, and Haut-Uele in the country's northeast. Response teams are now mobilized across six provinces total, attempting to trace contacts, isolate the sick, and slow transmission. At present, 619 people are reported to be receiving treatment or held in isolation, a fraction of the total caseload and a measure of how quickly the virus has outpaced the health system's capacity to respond.
The Bundibugyo strain presents a particular challenge because it differs from the Zaire strain, which has dominated previous outbreaks and for which some medical countermeasures exist. The Africa Centres for Disease Control and Prevention has investigated whether the Bundibugyo variant may have mutated in ways that make it more transmissible or severe, but those suspicions have not been confirmed by testing. Still, the absence of approved vaccines and treatments has left responders working with limited tools.
That situation may be beginning to shift. Clinical trials of two antiviral treatments commenced in early July, offering a potential pathway to therapies that could reduce mortality or shorten illness duration. More recently, a vaccine trial began using Ervebo, a vaccine already approved for use against the Zaire strain. Whether Ervebo will prove effective against Bundibugyo remains to be seen, but the initiation of these trials represents the first real opportunity to test medical interventions in real time as the outbreak unfolds. The coming weeks will determine whether these trials can generate usable data quickly enough to influence the trajectory of an epidemic that has already claimed nearly 3,000 lives and shows no signs of slowing.
Citazioni salienti
Experts believe there is a high number of unreported cases.— DR Congo communication ministry
Vuoi la storia completa?
Leggi l'originale su PerthNow ↗
Health & Medicine